Effects of Oral Nutritional Supplementation in Children at Risk of Undernutrition

Exclusion Criteria

• •Participant participates in another study that has not been approved as a concomitant study.
• •Child is known to have galactosemia, be allergic or intolerant to any ingredient found in the study product.
• •Child is currently drinking an Abbott product(s).
• •Child had a history of preterm delivery, defined as a birth before 37 completed weeks of gestation as reported by parent(s)/LG.
• •Child had birth weight \< 2500 g or \> 4000 g.
• •Child whose either parent has BMI ≥ 27.5 kg/m2
• •Child has continuous oral nutrition supplement (ONS) usage for at least 15 days in the past 1 month prior to screening. The standard ONS formula usually has an energy density of at least 1 kcal/mL, containing protein, carbohydrate and/or fat, as well as a wide range of micronutrients to supplement or use as the sole source of nutrition.
• •Child has current acute or chronic infections including but not restricted to respiratory infections, diarrhea, acute and chronic Hepatitis B or C, HIV infection or tuberculosis.
• •Child has been diagnosed with the following according to medical records or report by parent(s)/LG or the clinician's judgment:
• •1. Severe gastrointestinal disorders such as celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic (Exception: Intestinal parasites infection)
• •2. Neoplastic, renal, hepatic or cardiovascular, hormonal or metabolic disorders, congenital disease or genetic disorders such as atrial or ventricular wall defects, Down's syndrome, or thalassemia
• •3. Infantile anorexia nervosa, developmental disability, including physical disorders such as cerebral palsy, or developmental delay
• •4. Disorders of hemoglobin structure, function or synthesis
• •5. Clinically significant nutritional deficiency requiring specific treatment with another nutritional supplement (other than the study product) as diagnosed by the investigator.
• •6. Any other clinically significant medical condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.